Showing posts with label Kane Biotech. Show all posts
Showing posts with label Kane Biotech. Show all posts
Wednesday, September 5, 2007
Kane Biotech, diabetic foot ulcers's application
Sept. 4, 2007 - Kane Biotech's (TSX VENTURE:KNE) CSO prepares a report on the recent research related to the potential application of the Company's DispersinBTM technology together with bacteriophage for biofilm-based chronic wound treatment (diabetic foot ulcers included) . Kane Biotech's Press Release from Marketwire.
Subscribe to:
Posts (Atom)
